CSI Market
Sign In | Register

Casi Pharmaceuticals inc (CASIF) Annual Balance Sheets

Annual · GAAP · USD millions
Access CASIF quarterly Balance Sheets →
Looking at balance sheet data from Casi Pharmaceuticals inc through provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CASIF/balance-sheets
https://api.csimarket.com/api/v1/companies/CASIF/fundamentals
https://api.csimarket.com/api/v1/companies/CASIF/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent5.63
Marketable Securities1.72
Cash & Short-term Investments6.00
Accounts receivable4.09
Other Receivables0.00
Inventories0.84
Other Current Assets0.00
Income Taxes, Current1.20
Prepaid Expense And Other Assets Current2.14
Total Current Assets13.46
Equipment/Property/Plant Net7.09
Intangible Assets1.55
Long-term investments1.72
Tax Assets, Noncurrent5.43
Other Assets, Noncurrent5.00
Term Deposit Current-
Investment Equity Securities Fair Value-
Term Deposit Noncurrent-
Operating Lease Right Of Use Asset2.55
Total Assets25.65
Liabilities
Accounts Payable, Current AC24.17
Accrued Liabilities, Current7.58
Short-term Debt19.19
Other Liabilities, Current29.42
Taxes Payable0.48
Total Current Liabilities49.67
Long-term debt0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.73
Other liabilities, Noncurrent13.26
Convertible Notes Current4.24
Total Liabilities62.93
Stockholders' Equity
Redeemable Noncontrolling Interest Equity Redemption Value-
Common Stock Value0.00
Treasury Stock Value-9.60
Additional Paid In Capital Common Stock722.24
Retained Earnings / Accumulated Deficit-748.13
Accumulated Other Comprehensive Income-1.79
Other Equity-1.79
Common Stockholder's Equity-37.28
Non-controlling interests & other0.00
Total Stockholder's Equity-37.28
Liabilities & Stockholder's Equity25.65
4 historic quarters locked

Sign in to unlock the full Casi Pharmaceuticals inc balance sheet history.

Sign In Create Free Account

About Casi Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-061632

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI